Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Kenya"

33 News Found

Mandaviya chairs a high-level meeting to review elimination of Kala-Azar by 2023
Policy | January 05, 2023

Mandaviya chairs a high-level meeting to review elimination of Kala-Azar by 2023

The Government of India is supporting the states in active case detection, surveillance, treatment, supply of diagnostic kits, medicines, sprays etc.


Philips Foundation and RAD-AID International embark on a multi-year cross-continental partnership
News | September 14, 2022

Philips Foundation and RAD-AID International embark on a multi-year cross-continental partnership

Philips Foundation and RAD-AID International leverage Philips’ expertise in mobile ultrasound services to improve access to virtual care in hard-to-reach areas


Strides receives USFDA approval for Ibuprofen Oral Suspension
Drug Approval | May 30, 2022

Strides receives USFDA approval for Ibuprofen Oral Suspension

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)


Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek
Hospitals | May 11, 2022

Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek

The company also raised Rs 270 crore investment from Temasek in 2019


Panacea Biotec appoints NK Juneja as additional director
People | April 03, 2022

Panacea Biotec appoints NK Juneja as additional director

He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations


Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project


Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


Cipla’s Q3FY22 PAT at Rs 729 cr.
News | January 26, 2022

Cipla’s Q3FY22 PAT at Rs 729 cr.

Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.


Medicines Patent Pool finalises 27 generic manufacturers to produce molnupiravir
Drug Approval | January 21, 2022

Medicines Patent Pool finalises 27 generic manufacturers to produce molnupiravir

The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list


Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
News | January 20, 2022

Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool

They will commercialize molnupiravir in the international markets